Oral Listeria Vaccine Enhances Immunotherapy Response in Colorectal Cancer
Researchers at Stony Brook University developed an oral vaccine using modified Listeria monocytogenes that generates anti-tumor immune responses in the gut and significantly improves colorectal cancer control when combined with checkpoint inhibitors.